Jubilant Pharmova’s Roorkee unit gets VAI status
FDA has concluded that this inspection is 'closed'
FDA has concluded that this inspection is 'closed'
A significant proportion of healthcare professionals still tend to favor branded drugs
The facility will manufacture tablets, capsules, and injections for the oncology segment
Pharma Solutions operates 10 research and development and/or production sites globally
More than 10,000 scientific publications containing EUDRAGIT
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
Subscribe To Our Newsletter & Stay Updated